Tag: fluorouracil (5-FU)
Articles
- Latest research concerning side effects of chemotherapy
- Latest research on chemo brain after breast cancer treatment
News
- A story of long-term stage IV HER2+ breast cancer survival
- Adding the bisphosphonate zoledronic acid to chemotherapy does not improve outcome markers
- Apigenin enhances the anticancer activity of 5-FU chemotherapy
- Apigenin increases effectiveness of Taxol chemotherapy
- Chemotherapy might cause chemo brain by disrupting the formation of brain nerve cells
- Grapes and other foods might help protect against Adriamycin-induced heart damage
- Low white blood cell count as a result of chemotherapy indicates the treatment is working
- Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy
- Simultaneous chemotherapy plus radiation treatment reduces breast cancer recurrence
- Taking Celebrex might reduce the effectiveness of chemotherapy for breast cancer
- The beta blocker propranolol increases the effectiveness of Taxol
Foods
Studies
- 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
- ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer
- Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
- Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
- Cytoprotective effects of fucoidan, an algae-derived polysaccharide on 5-fluorouracil-treated dendritic cells
- Differential response from neoadjuvant chemotherapy across breast cancer subtypes
- In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine
- Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5
- Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
- Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
- Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- Response to influenza virus vaccination during chemotherapy in patients with breast cancer
- Surgery for widely disseminated breast cancer: prolonged control by excision of metastases
- Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial
- The role of neurogenesis in post-chemotherapy cognitive impairment
- Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials